MEK inhibitor AZD6244 inhibits the activation of ERK of colon cancer cells, while AZD6244 promotes JAK2-STAT3 signaling activation which induces colon cancer cell resistance to inhibitor. This evidence concerns the gene MAP2K7 and malignant colon neoplasm.